An Evaluation of Maternal Position During Cesarean Delivery

NCT ID: NCT02872181

Last Updated: 2018-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During Cesarean Delivery pregnant women are frequently tilted to the left 15 degress to reduce compression of the major blood vessels by the uterus. Despite this common practice, there is no conclusive evidence to support this practice. In fact it may even be deleterious to have women positioned in this position. The aim of the study is to determine whether or not tilting women to the left during cesarean section (CS) is helpful or detrimental. The authors hypothesize that left uterine displacement of 15 degrees, which is commonly employed, is useless for preventing compression of these blood vessels. To investigate this question, women will be randomly assigned to either be tilted 15 degrees to the left during CS or positioned flat on the table. Fetal acid base status, vasopressor/phenylephrine use, patient satisfaction, maternal complications, and fetal complications will all be collected and compared.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BMI <30

Pregnant women undergoing C/S with BMI \<30

Group Type EXPERIMENTAL

Supine

Intervention Type PROCEDURE

Placed in Supine position

Left uterine displacement

Intervention Type PROCEDURE

Placed in 15 degrees left uterine displacement

BMI 30-40

Pregnant women undergoing C/S with BMI 30-40

Group Type EXPERIMENTAL

Supine

Intervention Type PROCEDURE

Placed in Supine position

Left uterine displacement

Intervention Type PROCEDURE

Placed in 15 degrees left uterine displacement

BMI >40

Pregnant women undergoing C/S with BMI \>40

Group Type EXPERIMENTAL

Supine

Intervention Type PROCEDURE

Placed in Supine position

Left uterine displacement

Intervention Type PROCEDURE

Placed in 15 degrees left uterine displacement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supine

Placed in Supine position

Intervention Type PROCEDURE

Left uterine displacement

Placed in 15 degrees left uterine displacement

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* term pregnant women with an uncomplicated pregnancy course undergoing scheduled cesarean delivery

* ≥18 years old
* ASA 1 and 2 (i.e., patient is completely healthy (1) or has mild systemic disease (2)
* Able and willing to consent to participate

Exclusion Criteria

* Males

* \<18 years old
* maternal cardiac/pulmonary/hematologic disorders/renal failure
* drug/alcohol/tobacco use during pregnancy
* essential or pregnancy-induced hypertension
* diabetes greater than 10 years
* pre-eclampsia or abruptio placenta
* \<37 weeks gestation
* hemoglobin \< 7 g/dL
* intrauterine growth retardation
* fetal distress or fetal anomaly
* Transverse lie
* Ruptured membranes
* Severe polyhydramnios or oligohydramnios
* Multiple gestation
* severe scoliosis or kyphosis,
* uterine abnormalities (e.g., large fibroids, bicornuate uterus)
* Failed spinal (sensory level \< T6 after 15 minutes)
* need to convert to general anesthesia before delivery
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hartford Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

adam sachs, MD

Role: PRINCIPAL_INVESTIGATOR

Hartford Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hartford Hospital

Hartford, Connecticut, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

adam sachs, MD

Role: CONTACT

860-972-2117

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Adam Sachs, MD

Role: primary

860-972-2117

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HartfordH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.